We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

193 hedge funds and large institutions have $90.9M invested in Editas Medicine in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 48 increasing their positions, 52 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

207% more call options, than puts

Call options by funds: $1.83M | Put options by funds: $596K

78% more capital invested

Capital invested by funds: $51M → $90.9M (+$39.9M)

0% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 26

1% less funds holding

Funds holding: 194 → 193 (-1)

8% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 52

3.69% less ownership

Funds ownership: 53.03% → 49.34% (-3.7%)

Holders
193
Holders Change
-1
Holders Change %
-0.52%
% of All Funds
2.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
48
Reduced
52
Closed
26
Calls
$1.83M
Puts
$596K
Net Calls
+$1.24M
Net Calls Change
+$907K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$2.6M
2
WP
Woodline Partners
California
+$1.38M
3
N
Nuveen
North Carolina
+$1.04M
4
Citadel Advisors
Citadel Advisors
Florida
+$854K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$587K

Top Sellers

Rank Fund Capital Flow
1
UBS AM
UBS AM
Illinois
-$3.02M
2
Morgan Stanley
Morgan Stanley
New York
-$2.03M
3
UBS Group
UBS Group
Switzerland
-$959K
4
Bank of America
Bank of America
North Carolina
-$717K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$589K
Name Holding Trade Value Shares
Change 		Change in
Stake
S
126
SignatureFD
Georgia
$3.17K – – –
NA
127
NewEdge Advisors
Louisiana
$2.85K – – –
Jones Financial Companies
128
Jones Financial Companies
Missouri
$2.84K -$1.43K -875 -41%
TLCM
129
Twin Lakes Capital Management
California
$2.75K – – –
SHIM
130
Stone House Investment Management
Pennsylvania
$2.2K – – –
WSFS
131
Wilmington Savings Fund Society
Delaware
$2.2K – – –
Nisa Investment Advisors
132
Nisa Investment Advisors
Missouri
$2.05K -$2.15K -1,314 -59%
Optiver Holding
133
Optiver Holding
Netherlands
$1.75K – – –
LSA
134
Leonteq Securities AG
Switzerland
$1.67K – – –
EP
135
Essential Partners
California
$1.57K +$1.17K +713 New
TCM
136
Tradewinds Capital Management
Washington
$1.54K – – –
PS
137
Principal Securities
Iowa
$1.49K +$708 +433 +177%
PWA
138
Physician Wealth Advisors
Utah
$1.43K +$1.06K +649 New
SPIA
139
Steward Partners Investment Advisory
New York
$1.16K – – –
TWC
140
TD Waterhouse Canada
Ontario, Canada
$1.12K – – –
AWM
141
Ameliora Wealth Management
Switzerland
$1.1K – – –
HCM
142
Hollencrest Capital Management
California
$1.1K – – –
TCOT
143
Trust Company of Toledo
Ohio
$1.1K +$818 +500 New
AWM
144
AllSquare Wealth Management
New York
$1.04K – – –
Daiwa Securities Group
145
Daiwa Securities Group
Japan
$1K – – –
EWA
146
EverSource Wealth Advisors
Alabama
$983 +$2 +1 +0.2%
PFBT
147
Parkside Financial Bank & Trust
Missouri
$902 +$671 +410 New
Zurich Cantonal Bank
148
Zurich Cantonal Bank
Switzerland
$792 -$10.1K -6,192 -95%
FFO
149
Fortitude Family Office
Arizona
$715 +$532 +325 New
RWM
150
Rialto Wealth Management
New York
$715 +$532 +325 New
4 5
6
7 8

EDIT Hedge Fund Activity: Q2 2025 in Review

193 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2025, worth a combined $90.9M — up 78% from $51M a quarter earlier.

Fund positioning in EDIT was balanced in Q2 2025: 26 funds opened new positions, 26 closed out, 48 added to existing stakes and 52 trimmed.

The largest buyer was Millennium Management, adding an estimated $2.6M. The largest seller was UBS AM, exiting entirely with an estimated $3.02M sold.

  • 193 institutional investors held Editas Medicine (EDIT) as of Q2 2025, down from 194 in Q1 2025.
  • Funds reported $90.9M of Editas Medicine stock for Q2 2025, up 78% quarter-over-quarter.
  • 26 funds opened new Editas Medicine positions in Q2 2025 and 26 closed out, a net change of 0 holders.
  • The largest Editas Medicine buyer in Q2 2025 was Millennium Management, an estimated $2.6M added.
  • The largest Editas Medicine seller in Q2 2025 was UBS AM, an estimated $3.02M sold.

Based on aggregated 13F filings for Q2 2025.